Cypherpunk Technologies Reports Third Quarter 2026 Financial Results
First quarter of Zcash Mining: 8,967.29 ZEC Mined in 44 days, representing
at approximately
Company to host X Spaces event today,
"The launch of Cypherpunk Mining in August was transformative, as it enabled the production of ZEC alongside our purchases and contributes to the security of the Zcash network. In the first six weeks of operation, our fleet earned 8,967.29 ZEC as a result of an exceptional 95% uptime, all of which was added to our treasury in a momentous third quarter for the company," said
"The quarter marked a major milestone for Cypherpunk, and we are already planning for significant continued growth. We intend to increase our overall hashrate through additional equipment purchases with the goal of representing approximately 25% of the total Zcash network over time," said
Cypherpunk Highlights:
Launched Cypherpunk Mining, the world's largest Zcash mining fleet at launch
- On
August 17, 2026 , Cypherpunk Mining acquired fromMoria Mining, LLC , an affiliate ofWinklevoss Treasury Investments, LLC ("WTI"), Bitmain Antminer Z15 Pro Zcash mining machines, the colocation and hosting agreements under which those machines are installed and operated at three third-party hosting facilities, and related hosting deposits (the "Mining Asset Acquisition"). The purchase price of$33.33 million was paid through the issuance to WTI of a pre-funded warrant to purchase 43,290,042 shares of Cypherpunk common stock at an exercise price of$0.001 per share. - Cypherpunk's mining fleet launched on
August 18, 2026 , and at the time was the largest Zcash mining operation in the world. Cypherpunk's fleet has a deployed hashrate of approximately 4.2 GSol/s. At the closing of the Mining Asset Acquisition, Cypherpunk's fleet represented approximately 18% of total Zcash network hashrate. Cypherpunk's mining business is led byKevin Zhang , its Head of Mining, who joined the Company inAugust 2026 .
Key operating metrics
- Mining revenue was
$9.9 million for the three months endedSeptember 30, 2026 , Cypherpunk's first period of mining operations, and reflects 8,967.29 ZEC earned fromAugust 18, 2026 throughSeptember 30, 2026 , at an average fair value of$1,105.46 per ZEC. - Fleet operations demonstrated approximately 95% uptime.
- Total Zcash network hashrate increased from approximately 23 GSol/s at
August 18, 2026 to approximately 32 GSol/s as ofNovember 13, 2026 . Cypherpunk's share of network hashrate represents approximately 13.1% as ofNovember 13, 2026 . - Cost to mine one ZEC, excluding depreciation of mining equipment, was
$104.33 , or 9.44% of the production value of one ZEC mined. Cost to mine one ZEC, including depreciation of mining equipment, was$237.46 , or 21.48% of the production value of one ZEC mined.
Positioning the fleet to grow with the network
- To expand the mining fleet, in
September 2026 , Cypherpunk Mining entered into a letter of intent withBitmain Technologies Delaware Limited ("Bitmain") for the purchase of Bitmain's next-generation Zcash mining machines with a total purchase commitment of up to$30.0 million , of which$6.0 million was paid as a refundable deposit, with delivery expected in mid-2027. Completion of this transaction would expand Cypherpunk's mining fleet towards the goal of representing approximately 25% of the overall Zcash network hashrate as that hashrate increases over the next year.
October mining results of 5,721.35 ZEC
- In
October 2026 , Cypherpunk mined an additional 5,721.35 ZEC, all of which were added to the treasury, and achieved an uptime of approximately 97%.
ZEC treasury holdings increased to 341,858.75 ZEC
- Since the end of the third quarter, Cypherpunk acquired an additional 3,775.72 ZEC through open market purchases for approximately
$3.475 million at an average price of$920.40 per ZEC. - Including the recent open market purchases and the October mining results, Cypherpunk holds a total of 341,858.75 ZEC, representing approximately 2.01% of the circulating supply of ZEC. Cypherpunk's current stated objective is to accumulate holdings representing at least 5% of the circulating supply of ZEC over time.
- In
September 2026 , Cypherpunk appointedAmanda Fabiano to its Board of Directors. Fabiano currently serves as Chief Operating Officer of Nakamoto Inc., a publicly listed bitcoin-focused company, and as an independent director of TeraWulf Inc., a public bitcoin mining company that has expanded into AI and high-performance computing infrastructure. Previously, she held senior mining and investment roles at Galaxy and Fidelity.
Leap Therapeutics Subsidiary Highlights:
- Following publication of the randomized Phase 2 DeFianCe study in
Clinical Cancer Research inAugust 2026 , receipt of Fast Track designation inMay 2026 , and alignment with the FDA on the design of a registrational Phase 3 trial in aDKK1 -high 2L CRC population, Leap initiated a strategic process to identify the best path forward for sirexatamab and to secure the resources required to advance the program into Phase 3 development. The process may include financing the program as an independent entity or a strategic transaction with a pharmaceutical or biotechnology company, including a partnership, license, collaboration, sale or other business combination. There can be no assurance that the process will result in any transaction or financing, and the Company has not set a timetable for its conclusion.
Third Quarter 2026 Financial Results:
Cypherpunk recorded net income of
Mining revenue was
Cost of revenue (excluding depreciation and amortization) was
Depreciation expense related to Cypherpunk's mining equipment was
Research and development expenses were
General and administrative expenses were
During the three months ended
As of
X Spaces Details:
About Cypherpunk
Cypherpunk Technologies is a privacy technology company. The Company's mission is to advance technologies that guarantee privacy for humans on the internet. Cypherpunk pursues this mission through three primary strategies: mining Zcash through Cypherpunk Mining; accumulating Zcash through open market purchases; and investing in, acquiring, and building technologies that push the frontier of privacy forward. Additionally, through its subsidiary Leap Therapeutics, the Company is developing novel therapies for patients with cancer by continuing the development of sirexatamab and FL-501. For more information about the Company, visit our websites at http://www.cypherpunk.com and http://www.leaptx.com or view our public filings with the SEC that are available via EDGAR at http://www.sec.gov.
FORWARD-LOOKING STATEMENTS
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. Forward-looking statements address various matters including statements relating to the Company's ZEC mining operations, the hashpower represented by the acquired Z15 Pro machines, the Zcash flow or profitability of the Company's mining operations, the potential purchase of new Zcash mining machines, the comparative economics or profitability of Zcash mining relative to other digital infrastructure or mining activities, the future hashrate of the Zcash Network, the Company's target share of the Zcash network hashrate, the value of the Company's ZEC holdings, the Company's target percentage ownership of the ZEC supply, the expected future market, price, and liquidity of ZEC, the Company's expected use of Zcash flow or other capital generated by its mining operations, the potential value of the Company's investment in Zcash Open Development Labs ("ZODL"), the macro and political conditions surrounding Zcash or digital assets, the Company's plan for value creation and strategic advantages, market size and growth opportunities, regulatory conditions, competitive position and the interest of other corporations in similar business strategies, technological and market trends, and future financial condition and performance. Risks and uncertainties of the Company's strategy include, among others: (a) risks relating to the Company's operations and business, including the performance of the Company's Zcash mining machines and the highly volatile nature of the price of ZEC; (b) the risk that material changes in the price of ZEC, such as decreases in price, will result in significant changes to the Company's financial statements, such as unrealized losses on fair value of ZEC holdings, and reduced net income or increased net loss; (c) the risk that material changes in the hashrate of the Zcash Network, such as increases in hashrate, will result in significant changes to the Company's financial statements, such as reduced revenue, reduced gross margins, and reduced net income or increased net loss; (d) the risk that the price of the Company's common stock may be highly correlated to the price of ZEC; (e) the risk that the Company will fail to realize the anticipated benefits of the ZEC mining operation or digital asset treasury strategy; (f) risks related to the custody of our ZEC and our reliance on Gemini Space Station and its affiliates for trading and custody services; (g) changes in business, market, financial, political and regulatory conditions; (h) risks related to increased competition in the industries in which the Company does and will operate; (i) risks relating to significant legal, commercial, regulatory and technical uncertainty regarding digital assets generally; (j) risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; (k) risks related to the Company's dependence on third-party hosting facilities and service providers for its mining operations; and (l) the risk that the Company does not enter into a definitive agreement to purchase next-generation Zcash mining machines, or that such machines are not delivered on the expected timetable, at the expected price, or with the expected performance, or at all.
With respect to our biotechnology operations, important factors that could cause actual results to differ materially from our plans, estimates or expectations could include, but are not limited to: (i) the DeFianCe study did not meet its prespecified primary endpoint of progression-free survival in the intent-to-treat population; (ii) the DKK1 biomarker subgroup and interaction analyses were exploratory and may not be replicated in a prospective clinical trial; (iii) the Company's ability to obtain additional capital to advance sirexatamab on acceptable terms or at all; and (iv) that risk that the strategic process may not result in any transaction or financing, may be terminated at any time, and any resulting transaction may not be on terms favorable to the Company or its stockholders.
New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. The Company may not actually achieve the forecasts disclosed in such forward-looking statements, and you should not place undue reliance on such forward-looking statements. Such forward-looking statements are subject to a number of material risks and uncertainties including but not limited to those set forth under the caption "Risk Factors" in the Company's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 filed with the SEC, or as may be included in other reports or information we file with the SEC, as well as discussions of potential risks, uncertainties, and other important factors in its subsequent filings with the SEC. Any forward-looking statement speaks only as of the date on which it was made. Neither the Company, nor any of its affiliates, advisors or representatives, undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date hereof.
Cypherpunk™, Cypherpunk Mining™, Cypherpunk Technologies™, and the Cypherpunk logo™ are all trademarks of Cypherpunk Technologies Inc.
|
|
||||||||||
|
Consolidated Balance Sheets |
||||||||||
|
(in thousands, except share and per share amounts) |
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2026 |
|
2025 |
|
|
|
|
|
|
|
|
|
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|||
|
Current assets: |
|
|
|
|
||||||
|
|
Cash and cash equivalents |
|
$ 55,988 |
|
$ 14,035 |
|||||
|
|
Digital assets receivable |
|
470,146 |
|
147,404 |
|||||
|
|
Research and development incentive receivable |
|
- |
|
602 |
|||||
|
|
Prepaid expenses and other current assets |
|
308 |
|
40 |
|||||
|
|
|
|
|
|
Total current assets |
|
526,442 |
|
162,081 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Property and equipment, net |
|
28,811 |
|
- |
|||||
|
|
Right of use assets, net |
|
38 |
|
38 |
|||||
|
|
Deferred costs |
|
242 |
|
401 |
|||||
|
|
Deposits |
|
|
6,815 |
|
662 |
||||
|
|
Other investment |
|
5,000 |
|
- |
|||||
|
|
|
|
|
|
Total assets |
|
$ 567,348 |
|
$ 163,182 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders' Equity |
|
|
|
|
||||||
|
Current liabilities: |
|
|
|
|
||||||
|
|
Accounts payable |
|
$ 975 |
|
$ 1,981 |
|||||
|
|
Accrued expenses |
|
1,261 |
|
2,067 |
|||||
|
|
Income tax payable |
|
111 |
|
472 |
|||||
|
|
Lease liability |
|
38 |
|
38 |
|||||
|
|
|
|
|
|
Total current liabilities |
|
2,385 |
|
4,558 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current liabilities: |
|
|
|
|
||||||
|
|
Deferred tax liability |
|
29,404 |
|
5,118 |
|||||
|
|
|
|
|
|
Total liabilities |
|
31,789 |
|
9,676 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
||||||
|
|
Preferred stock, |
|
- |
|
- |
|||||
|
|
Common stock, issued and outstanding as of |
|
144 |
|
84 |
|||||
|
|
Stock subscription receivable |
|
- |
|
(150) |
|||||
|
|
Additional paid-in capital |
|
729,813 |
|
616,216 |
|||||
|
|
Accumulated other comprehensive loss |
|
(77) |
|
(95) |
|||||
|
|
Accumulated deficit |
|
(194,321) |
|
(462,549) |
|||||
|
|
|
|
|
|
Total stockholders' equity |
|
535,559 |
|
153,506 |
|
|
|
|
|
|
|
Total liabilities and stockholders' equity |
|
$ 567,348 |
|
$ 163,182 |
|
|
|
|
|||||||||||||
|
|
Consolidated Statements of Operations |
|||||||||||||
|
|
(in thousands, except share and per share amounts) |
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited) |
|
(Unaudited) |
||||
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
||||
|
|
|
|
|
|
|
|
|
2026 |
|
2025 |
|
2026 |
|
2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mining revenue |
|
$ 9,913 |
|
$ - |
|
$ 9,913 |
|
$ - |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating costs and expenses: |
|
|
|
|
|
|
|
|
||||||
|
|
Cost of revenue (excluding depreciation and amortization) |
|
936 |
|
- |
|
936 |
|
- |
|||||
|
|
Research and development |
|
233 |
|
1,247 |
|
591 |
|
24,695 |
|||||
|
|
General and administrative |
|
4,944 |
|
1,919 |
|
14,092 |
|
6,742 |
|||||
|
|
Depreciation and amortization |
|
1,194 |
|
- |
|
1,194 |
|
- |
|||||
|
|
Restructuring charges |
|
- |
|
- |
|
- |
|
4,527 |
|||||
|
|
|
|
Total operating costs and expenses |
|
7,307 |
|
3,166 |
|
16,813 |
|
35,964 |
|||
|
Income (loss) from operations |
|
2,606 |
|
(3,166) |
|
(6,900) |
|
(35,964) |
||||||
|
Interest income |
|
59 |
|
123 |
|
217 |
|
806 |
||||||
|
Interest expense |
|
(2) |
|
(10) |
|
(15) |
|
(23) |
||||||
|
Australian research and development incentives |
|
- |
|
(56) |
|
- |
|
- |
||||||
|
Change in fair value of embedded derivative |
|
330,846 |
|
- |
|
299,284 |
|
- |
||||||
|
Foreign currency gains |
|
- |
|
8 |
|
1 |
|
2 |
||||||
|
Income (loss) before income taxes |
|
333,509 |
|
(3,101) |
|
292,587 |
|
(35,179) |
||||||
|
Provision for income taxes |
|
(27,504) |
|
(202) |
|
(24,359) |
|
- |
||||||
|
Net income (loss) attributable to common stockholders |
|
$ 306,005 |
|
$ (3,303) |
|
$ 268,228 |
|
$ (35,179) |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share |
|
|
|
|
|
|
|
|
||||||
|
|
|
|
Basic |
|
$ 1.44 |
|
$ (0.08) |
|
$ 1.42 |
|
$ (0.85) |
|||
|
|
|
|
Diluted |
|
$ 1.13 |
|
$ (0.08) |
|
$ 1.17 |
|
$ (0.85) |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding |
|
|
|
|
|
|
|
|
||||||
|
|
|
|
Basic |
|
|
212,440,711 |
|
41,444,979 |
|
188,453,303 |
|
41,386,929 |
||
|
|
|
|
Diluted |
|
271,933,041 |
|
41,444,979 |
|
230,134,265 |
|
41,386,929 |
|||
|
|
||||||||||||||
|
Condensed Consolidated Statements of Cash Flows |
||||||||||||||
|
(in thousands) |
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited) |
|
|
(Unaudited) |
||||
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
||||
|
|
|
|
|
|
|
|
2026 |
|
2025 |
|
|
2026 |
|
2025 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Cash used in operating activities |
$ (2,902) |
|
$ (8,317) |
|
|
$ (9,024) |
|
$ (37,283) |
||||||
|
Cash used in investing activities |
(6,000) |
|
- |
|
|
(24,544) |
|
- |
||||||
|
Cash provided by (used in) financing activities |
57,259 |
|
(121) |
|
|
75,501 |
|
(301) |
||||||
|
Effect of exchange rate changes on cash and cash equivalents |
7 |
|
(6) |
|
|
20 |
|
21 |
||||||
|
Net increase (decrease) in cash and cash equivalents |
48,364 |
|
(8,444) |
|
|
41,953 |
|
(37,563) |
||||||
|
Cash and cash equivalents at beginning of period |
7,624 |
|
18,130 |
|
|
14,035 |
|
47,249 |
||||||
|
Cash and cash equivalents at end of period |
$ 55,988 |
|
$ 9,686 |
|
|
$ 55,988 |
|
$ 9,686 |
||||||
CONTACT:
President & Chief Executive Officer
617-714-0360
For Media:
Head of Communications
954-294-3249
jacqueline@cypherpunk.com
For Investors:
Investor Relations
212-600-1902
leap@argotpartners.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cypherpunk-technologies-reports-third-quarter-2026-financial-results-302939814.html
SOURCE